DeepMed Research

Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Bedside Ultrasound in Detection of Pneumothorax Post Transthoracic Lung Biopsy

Not Applicable

Completed

Conditions: Pneumothorax

Interventions: Device: Ultrasound (US) Imaging

First Posted Date: 2018-01-11

Last Posted Date: 2021-09-05

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 37

Registration Number: NCT03397290

Locations: 🇨🇦
Hamid Bayanati, Ottawa, Ontario, Canada

The Use of Laparoscopic Transversus Abdominis Plane Block in Gastric Bypass Surgery (LapTAP)

Phase 4

Conditions: Bariatric Surgery Candidate

Interventions: Drug: Normal saline
Drug: Ropivacaine

First Posted Date: 2017-12-11

Last Posted Date: 2019-11-06

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 150

Registration Number: NCT03367728

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Cellular Immunotherapy for Septic Shock

Phase 2

Conditions: Shock
Systemic Inflammatory Response Syndrome
Sepsis
Infection
Inflammation
Septic Shock
Pathologic Processes

Interventions: Biological: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells
Other: Placebo

First Posted Date: 2017-12-11

Last Posted Date: 2017-12-11

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 114

Registration Number: NCT03369275

Development and Validation of a Preoperative Frailty Index Using Health Administrative Data

Completed

Conditions: Surgery
Predictive Value of Tests
Frail Elderly Syndrome
Outcomes

Interventions: Diagnostic Test: Frailty index

First Posted Date: 2017-11-28

Last Posted Date: 2017-11-28

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 200000

Registration Number: NCT03354546

Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients

Phase 4

Completed

Conditions: Early-stage Breast Cancer
Pain Syndrome

Interventions: Drug: Dexamethasone physician choice
Drug: Dexamethasone tapering dose

First Posted Date: 2017-11-21

Last Posted Date: 2020-01-09

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 124

Registration Number: NCT03348696

Locations: 🇨🇦
Southlake Regional Cancer Centre, Newmarket, Ontario, Canada
🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

An Innovative Trial Assessing Donor Sex on Recipient Mortality

Phase 4

Conditions: Red Blood Cell Transfusion

Interventions: Other: RBC Transfusion from male donor
Other: RBC Transfusion from female donor

First Posted Date: 2017-11-17

Last Posted Date: 2022-06-16

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 8850

Registration Number: NCT03344887

Locations: 🇨🇦
Ottawa Hospital - General Campus, Ottawa, Ontario, Canada

COPD Care Model on Clinical and Patient-Reported Outcomes

Completed

Conditions: COPD Exacerbation

First Posted Date: 2017-11-06

Last Posted Date: 2020-12-04

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 58

Registration Number: NCT03332394

Locations: 🇨🇦
The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada

Comparative Effectiveness of Peripheral Nerve Blocks for Outpatient Shoulder Surgery

Completed

Conditions: Postoperative Complications

Interventions: Other: Peripheral nerve blockade
Other: No peripheral nerve blockade

First Posted Date: 2017-10-13

Last Posted Date: 2025-01-06

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 1623

Registration Number: NCT03309644

Locations: 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

SAHaRA: A Randomized Controlled Trial

Not Applicable

Completed

Conditions: Subarachnoid Hemorrhage, Aneurysmal

Interventions: Other: Liberal RBC Transfusion Strategy
Other: Restrictive RBC Transfusion Strategy

First Posted Date: 2017-10-13

Last Posted Date: 2024-11-06

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 742

Registration Number: NCT03309579

Locations: 🇺🇸
University of Colorado School of Medicine, Aurora, Colorado, United States
🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺
Prince of Wales Hospital, Randwick, New South Wales, Australia

and more 20 locations

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Phase 2

Terminated

Conditions: Venous Thromboembolism
Obesity
Cancer

Interventions: Biological: Dalteparin

First Posted Date: 2017-09-29

Last Posted Date: 2024-01-23

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 92

Registration Number: NCT03297359

Locations: 🇨🇦
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada
🇨🇦
Juravinski Hospital, Hamilton, Ontario, Canada
🇨🇦
Alberta Health Services, Edmonton, Alberta, Canada

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy